| scholarly article | Q13442814 |
| P50 | author | Niels Høiby | Q12328808 |
| Søren Molin | Q26883279 | ||
| Helle Krogh Johansen | Q30004123 | ||
| Line E Thomsen | Q39994586 | ||
| Oana Ciofu | Q40705960 | ||
| Lars Jelsbak | Q47503093 | ||
| Lei Yang | Q57207718 | ||
| Janus A J Haagensen | Q114536714 | ||
| P2093 | author name string | Anne-Louise Frost | |
| Regitze Thøgersen | |||
| P2860 | cites work | Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis | Q28776658 |
| Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients | Q29615301 | ||
| Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge | Q33748666 | ||
| Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis | Q33769205 | ||
| Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients | Q33963695 | ||
| Structure of Pseudomonas aeruginosa populations analyzed by single nucleotide polymorphism and pulsed-field gel electrophoresis genotyping. | Q34435605 | ||
| Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives | Q35535180 | ||
| Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection | Q35555504 | ||
| Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients | Q35573139 | ||
| Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis | Q35773317 | ||
| Mucoid-to-nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation | Q35979967 | ||
| Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients | Q36528781 | ||
| Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis | Q36532113 | ||
| Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success?--A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection | Q38479070 | ||
| A major Pseudomonas aeruginosa clone common to patients and aquatic habitats | Q39915020 | ||
| Short-sighted evolution and the virulence of pathogenic microorganisms | Q40739465 | ||
| Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. | Q41091925 | ||
| Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis | Q41144869 | ||
| Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark | Q41145157 | ||
| Caenorhabditis elegans is a model host for Listeria monocytogenes | Q41901568 | ||
| Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis | Q42561285 | ||
| A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. | Q42604401 | ||
| Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units | Q42632850 | ||
| Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization | Q43745856 | ||
| An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre | Q44021808 | ||
| Mucoid Pseudomonas aeruginosa resists nonopsonic phagocytosis by human neutrophils and macrophages | Q44541788 | ||
| Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients. | Q46681339 | ||
| Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis | Q47793000 | ||
| Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales | Q50146857 | ||
| Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. | Q50674363 | ||
| Conserved virulence factors of Pseudomonas aeruginosa are required for killing Bacillus subtilis. | Q51324870 | ||
| Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection. | Q51659562 | ||
| Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. | Q51702027 | ||
| Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center. | Q51705466 | ||
| An Organ-Specific Differentiation Gene, pha-1, from Caenorhabditis elegans. | Q52239599 | ||
| Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. | Q53996192 | ||
| Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients | Q59139155 | ||
| Epidemiology of Pseudomonas aeruginosa in cystic fibrosis and the possible role of contamination by dental equipment | Q59139173 | ||
| Epidemiology Of Chronic Pseudomonas aeruginosa Infections In Cystic Fibrosis | Q59334968 | ||
| Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey | Q66902144 | ||
| Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients | Q72218258 | ||
| Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis | Q73335181 | ||
| Pseudomonas aeruginosa cross-infection among patients with cystic fibrosis during a winter camp | Q73471944 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pseudomonas aeruginosa | Q31856 |
| cystic fibrosis | Q178194 | ||
| P304 | page(s) | 2214-2224 | |
| P577 | publication date | 2007-01-29 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients | |
| P478 | volume | 75 |
| Q35800789 | A case of failed eradication of cystic fibrosis-related sinus colonisation by Pseudomonas aeruginosa |
| Q42638018 | A diagnostic PCR assay for the detection of an Australian epidemic strain of Pseudomonas aeruginosa |
| Q38059441 | Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective |
| Q37552351 | Advances in understanding Pseudomonas |
| Q36968815 | Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. |
| Q93270599 | Allelic polymorphism shapes community function in evolving Pseudomonas aeruginosa populations |
| Q53683178 | Analysis of Phylogenetic Variation of Stenotrophomonas maltophilia Reveals Human-Specific Branches. |
| Q30336845 | Archetypal analysis of diverse Pseudomonas aeruginosa transcriptomes reveals adaptation in cystic fibrosis airways |
| Q40669189 | Association between clinical antibiotic resistance and susceptibility of Pseudomonas in the cystic fibrosis lung. |
| Q33996153 | Bacterial adaptation during chronic infection revealed by independent component analysis of transcriptomic data |
| Q40356497 | Bacterial competition and quorum-sensing signalling shape the eco-evolutionary outcomes of model in vitro phage therapy |
| Q38103942 | Bacterial genome evolution within a clonal population: from in vitro investigations to in vivo observations |
| Q38031603 | Bacterial pathogens: from natural ecosystems to human hosts |
| Q44462802 | Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis |
| Q54965504 | Bacteriocin-mediated competition in cystic fibrosis lung infections. |
| Q39696154 | Cellular responses of A549 alveolar epithelial cells to serially collected Pseudomonas aeruginosa from cystic fibrosis patients at different stages of pulmonary infection |
| Q37812469 | Challenging and emerging pathogens in cystic fibrosis |
| Q50531928 | Changing rates of chronic Pseudomonas aeruginosa infections in cystic fibrosis: a population-based cohort study. |
| Q38207078 | Chronic pulmonary pseudomonal infection in patients with cystic fibrosis: A model for early phase symbiotic evolution |
| Q38660482 | Clinical care of children with primary ciliary dyskinesia |
| Q39218303 | Clinical implications of Pseudomonas aeruginosa location in the lungs of patients with cystic fibrosis |
| Q35350270 | Coexistence and within-host evolution of diversified lineages of hypermutable Pseudomonas aeruginosa in long-term cystic fibrosis infections. |
| Q89668220 | Combining Standard Molecular Typing and Whole Genome Sequencing to Investigate Pseudomonas aeruginosa Epidemiology in Intensive Care Units |
| Q35689537 | Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes |
| Q35023645 | Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis |
| Q39097378 | Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis |
| Q37410538 | Cross-sectional and longitudinal multilocus sequence typing of pseudomonas aeruginosa in cystic fibrosis sputum samples |
| Q36623329 | Cystic fibrosis: a mucosal immunodeficiency syndrome. |
| Q37775628 | Defining routes of airborne transmission of Pseudomonas aeruginosa in people with cystic fibrosis |
| Q40961535 | Defining the Pseudomonas genus: where do we draw the line with Azotobacter? |
| Q40142398 | Diversity, Prevalence, and Longitudinal Occurrence of Type II Toxin-Antitoxin Systems of Pseudomonas aeruginosa Infecting Cystic Fibrosis Lungs |
| Q38202864 | Ecological and temporal constraints in the evolution of bacterial genomes. |
| Q30017431 | Effect of Shear Stress on Pseudomonas aeruginosaIsolated from the Cystic Fibrosis Lung |
| Q40061924 | Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of P. aeruginosa pneumonia |
| Q34229846 | Environmental heterogeneity drives within-host diversification and evolution of Pseudomonas aeruginosa |
| Q54408648 | Evaluation of the efficacy of real-time polymerase chain reaction for the routine early detection of Pseudomonas aeruginosa in cystic fibrosis sputum and throat swab specimens |
| Q39997040 | Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection |
| Q34277284 | Evolution of Burkholderia pseudomallei in recurrent melioidosis |
| Q34937408 | Evolutionary dynamics of bacteria in a human host environment |
| Q38417030 | Evolutionary insight from whole-genome sequencing of Pseudomonas aeruginosa from cystic fibrosis patients |
| Q30539692 | Evolutionary remodeling of global regulatory networks during long-term bacterial adaptation to human hosts |
| Q37508105 | From environment to man: genome evolution and adaptation of human opportunistic bacterial pathogens |
| Q40798144 | Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study |
| Q52620575 | Generalized Growth of Estuarine, Household and Clinical Isolates of Pseudomonas aeruginosa. |
| Q34310496 | Genetic diversity of Burkholderia contaminans isolates from cystic fibrosis patients in Argentina |
| Q38636624 | Genome Sequence of Pseudomonas aeruginosa Strain DK1-NH57388A, a Stable Mucoid Cystic Fibrosis Isolate |
| Q34117003 | Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients' airways and antimicrobial therapy. |
| Q39656697 | Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections |
| Q64112175 | Genotypic characterization of isolates from Turkish children with cystic fibrosis |
| Q56891272 | High-resolution in situ transcriptomics of Pseudomonas aeruginosa unveils genotype independent patho-phenotypes in cystic fibrosis lungs |
| Q33701690 | Host imprints on bacterial genomes--rapid, divergent evolution in individual patients |
| Q36540547 | In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections |
| Q42206103 | Infection prevention and control guideline for cystic fibrosis: 2013 update |
| Q36099548 | Is genotyping of single isolates sufficient for population structure analysis of Pseudomonas aeruginosa in cystic fibrosis airways? |
| Q86429535 | Keeping an eye on P. aeruginosa |
| Q58715300 | Life in the cystic fibrosis upper respiratory tract influences competitive ability of the opportunistic pathogen Pseudomonas aeruginosa |
| Q36008300 | Long-term social dynamics drive loss of function in pathogenic bacteria |
| Q41871203 | Loss of social behaviours in populations of Pseudomonas aeruginosa infecting lungs of patients with cystic fibrosis |
| Q40927845 | Low-level resistance and clonal diversity of Pseudomonas aeruginosa among chronically colonized cystic fibrosis patients |
| Q51173006 | Microbial ecology and adaptation in cystic fibrosis airways. |
| Q91749955 | Microbial evolutionary medicine: from theory to clinical practice |
| Q39721947 | Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients |
| Q34500683 | Molecular epidemiology of chronic Pseudomonas aeruginosa airway infections in cystic fibrosis |
| Q59139095 | Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients |
| Q42584844 | Multiple-locus variable-number tandem-repeat analysis for longitudinal survey of sources of Pseudomonas aeruginosa infection in cystic fibrosis patients. |
| Q41415884 | Next generation sequencing reveals the antibiotic resistant variants in the genome of Pseudomonas aeruginosa |
| Q37413900 | Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host-pathogen interactions in cystic fibrosis |
| Q61449168 | Persistence and Microevolution of in the Cystic Fibrosis Lung: A Single-Patient Longitudinal Genomic Study |
| Q93379629 | Persistent Infection and Long-Term Carriage of Typhoidal and Nontyphoidal Salmonellae |
| Q81299848 | Phenotypic and genotypic characterization of Pseudomonas aeruginosa from cystic fibrosis patients |
| Q37068359 | Phenotypic characterization and PCR-Ribotypic profile of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Iran |
| Q35686899 | Phenotypic diversity within a Pseudomonas aeruginosa population infecting an adult with cystic fibrosis |
| Q37071140 | Population-level virulence factors amongst pathogenic bacteria: relation to infection outcome |
| Q40421266 | Pre-adapting parasitic phages to a pathogen leads to increased pathogen clearance and lowered resistance evolution with Pseudomonas aeruginosa cystic fibrosis bacterial isolates |
| Q60044193 | Privatisation rescues function following loss of cooperation |
| Q34999578 | Pseudomonas aeruginosa adaptation to lungs of cystic fibrosis patients leads to lowered resistance to phage and protist enemies |
| Q28299966 | Pseudomonas aeruginosa biofilms in cystic fibrosis |
| Q37451717 | Pseudomonas aeruginosa genotype prevalence in Dutch cystic fibrosis patients and age dependency of colonization by various P. aeruginosa sequence types. |
| Q38833703 | Pseudomonas aeruginosa infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches |
| Q30913394 | Pseudomonas aeruginosa population structure revisited |
| Q37502050 | Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis |
| Q33559774 | Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients |
| Q33862073 | Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis |
| Q35761876 | Selective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung |
| Q39922654 | Short-sighted evolution of bacterial opportunistic pathogens with an environmental origin |
| Q41677148 | Simultaneous sinus and lung infections in patients with primary ciliary dyskinesia |
| Q41710256 | Sinus biofilms in patients with cystic fibrosis: is adjusted eradication therapy needed? |
| Q40438847 | Sinus surgery can improve quality of life, lung infections, and lung function in patients with primary ciliary dyskinesia |
| Q35808789 | The Effects of CFTR and Mucoid Phenotype on Susceptibility and Innate Immune Responses in a Mouse Model of Pneumococcal Lung Disease. |
| Q38240975 | The Role of Human Beta-Defensin-2 in Pseudomonas aeruginosa Pulmonary Infection in Cystic Fibrosis Patients |
| Q42650446 | The deletion of TonB-dependent receptor genes is part of the genome reduction process that occurs during adaptation of Pseudomonas aeruginosa to the cystic fibrosis lung. |
| Q34022518 | The distributed genome hypothesis as a rubric for understanding evolution in situ during chronic bacterial biofilm infectious processes |
| Q53701654 | Transmission and lineage displacement drive rapid population genomic flux in cystic fibrosis airway infections of a Pseudomonas aeruginosa epidemic strain. |
| Q42280838 | Typing of Pseudomonas aeruginosa from hemorrhagic pneumonia in mink (Neovison vison). |
| Q37206311 | What makes pathogens pathogenic |
| Q36060289 | Within-Host Evolution of the Dutch High-Prevalent Pseudomonas aeruginosa Clone ST406 during Chronic Colonization of a Patient with Cystic Fibrosis. |
| Q39254205 | Within-host evolution of Pseudomonas aeruginosa reveals adaptation toward iron acquisition from hemoglobin. |
Search more.